These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 9148576

  • 1. [The graft-vs-host reaction in military transfusion treatment].
    Shevchenko IuL, Danil'chenko VV, Zhiburt EB, Serebrianaia NB, Katkova IV, Khubulava GG.
    Voen Med Zh; 1997 Feb; 318(2):32-5. PubMed ID: 9148576
    [No Abstract] [Full Text] [Related]

  • 2. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
    Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
    [No Abstract] [Full Text] [Related]

  • 3. [Monitoring of graft versus host (GVH) reaction and host versus graft (HVG) reaction].
    Tanaka S, Orita K.
    Nihon Rinsho; 1990 Sep; 48(9):2041-7. PubMed ID: 2232208
    [No Abstract] [Full Text] [Related]

  • 4. The influence of transfusions from unrelated donors upon marrow grafts between histocompatible canine siblings.
    Storb R, Rudolph RH, Graham TC, Thomas ED.
    J Immunol; 1971 Aug; 107(2):409-13. PubMed ID: 4398184
    [No Abstract] [Full Text] [Related]

  • 5. [Graft-versus-host disease].
    Hashimoto E, Hayashi N.
    Ryoikibetsu Shokogun Shirizu; 1995 Aug; (8):453-6. PubMed ID: 8581679
    [No Abstract] [Full Text] [Related]

  • 6. Acute graft-versus-host disease in allogeneic marrow transplantation.
    Parker N, Cohen T.
    Nurs Clin North Am; 1983 Sep; 18(3):569-77. PubMed ID: 6351023
    [No Abstract] [Full Text] [Related]

  • 7. Experimental aspects of bone marrow transplantation in primates.
    Balner H, Dicke KA, van Putten LM, van Bekkum DW.
    Transplant Proc; 1969 Mar; 1(1):25-30. PubMed ID: 4400066
    [No Abstract] [Full Text] [Related]

  • 8. [Transfusion associated graft versus host disease (TA-GVHD)].
    Takahashi K.
    Ryoikibetsu Shokogun Shirizu; 1998 Mar; (22 Pt 3):605-8. PubMed ID: 9851229
    [No Abstract] [Full Text] [Related]

  • 9. [Blood transfusion and transplantation].
    Ishikura H, Endo J.
    Rinsho Byori; 1991 Jul; Suppl 90():139-50. PubMed ID: 1920850
    [No Abstract] [Full Text] [Related]

  • 10. Transfusion-associated graft-versus-host disease.
    Dwyre DM, Holland PV.
    Vox Sang; 2008 Aug; 95(2):85-93. PubMed ID: 18544121
    [Abstract] [Full Text] [Related]

  • 11. Transfusion-associated graft-versus-host disease.
    Rühl H, Bein G, Sachs UJ.
    Transfus Med Rev; 2009 Jan; 23(1):62-71. PubMed ID: 19056035
    [Abstract] [Full Text] [Related]

  • 12. Transfusions and graft-versus-host disease.
    Lancet; 1989 Mar 11; 1(8637):529-30. PubMed ID: 2564061
    [No Abstract] [Full Text] [Related]

  • 13. Fatal graft-vs.-host reaction following transfusion of allogeneic blood and plasma in infants with combined immunodeficiency disease.
    Park BH, Good RA, Gate J, Burke B.
    Transplant Proc; 1974 Dec 11; 6(4):385-7. PubMed ID: 4155155
    [No Abstract] [Full Text] [Related]

  • 14. [Graft versus host disease: the most threatening complication of bone marrow transplant. Review of the literature].
    Rasero L, Bonavita K, Marsullo M.
    Assist Inferm Ric; 2002 Dec 11; 21(4):211-21. PubMed ID: 12674033
    [No Abstract] [Full Text] [Related]

  • 15. Cyclosporin A and mini short-term methotrexate vs cyclosporin A as graft-versus-host disease prophylaxis in patients with beta thalassemia major undergoing allogeneic blood and marrow transplantation.
    Iravani M, Mousavi A, Gholibeikian S, Bahar B, Samiee S, Ashouri A, Eghbal L, Ghavamzadeh A.
    Bone Marrow Transplant; 2005 Jun 11; 35(11):1095-9. PubMed ID: 15821773
    [Abstract] [Full Text] [Related]

  • 16. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.
    Pelot MR, Pearson DA, Swenson K, Zhao G, Sachs J, Yang YG, Sykes M.
    Biol Blood Marrow Transplant; 1999 Jun 11; 5(3):133-43. PubMed ID: 10392959
    [Abstract] [Full Text] [Related]

  • 17. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S, Kim JC, Whitaker-Menezes D, Murphy GF, Friedman TM, Korngold R.
    Biol Blood Marrow Transplant; 2004 Oct 11; 10(10):669-80. PubMed ID: 15389433
    [Abstract] [Full Text] [Related]

  • 18. Determination of the radiation dose on blood components to prevent post-transfusional graft-vs-host reaction.
    Fagiolo E, Pozzetto A, Cellini N, Valentini V.
    Haematologica; 1983 Oct 11; 68(5):573-80. PubMed ID: 6416937
    [No Abstract] [Full Text] [Related]

  • 19. Bone marrow transplantation. Aggravating factors in graft-versus-host disease.
    Hong R, Bach FH.
    Transplantation; 1970 Aug 11; 10(2):192-3. PubMed ID: 4393684
    [No Abstract] [Full Text] [Related]

  • 20. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
    Petersen SL, Madsen HO, Ryder LP, Svejgaard A, Masmas TN, Dickmeiss E, Heilmann C, Vindeløv LL.
    Biol Blood Marrow Transplant; 2004 May 11; 10(5):337-46. PubMed ID: 15111933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.